Coloplast study demonstrates significant improvements with Provox Life
A new study from Danish medtech firm Coloplast shows a significant improvement in pulmonary symptoms when laryngectomy patients use the company’s device Provox Life.
by marketwire, translated by daniel pedersen
On Wednesday, Coloplast publicized a study demonstrating a significant improvement in laryngectomy patients’ pulmonary symptoms when using the device Provox Life, the company reports in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Coloplast acquires Atos Medical for USD 2.5bn
For subscribers
Britt Meelby Jensen steps down as CEO of Atos Medical
For subscribers
.jpg&w=384&q=75)
